{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-002284","form_type":"8-K","ticker":null,"cik":"0001331612","company_name":"AnTix Holdings, Inc.","filed_at":"2024-04-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.971279+00:00","generated_at":"2026-06-03T13:36:39.390226+00:00","sec_items":["5.02","8.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Innovative MedTech fires CEO Merle Griff; faces $1.84M royalty lawsuit","bullets":["CEO Merle Griff terminated April 18, 2024; Michael Friedman (President/CFO) appointed CEO.","Lawsuit filed April 17, 2024 by SarahCare shareholders alleging breach of contract for unpaid royalties.","Plaintiffs seek $1,841,537.01 in damages plus interest, costs, and attorney fees.","Company intends to vigorously defend the litigation."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-002284","json":"https://secwatch.observer/filing/0001477932-24-002284.json","markdown":"https://secwatch.observer/filing/0001477932-24-002284.md","text":"https://secwatch.observer/filing/0001477932-24-002284.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1331612/000147793224002284/0001477932-24-002284-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1331612/000147793224002284/imth_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T13:36:39.390226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3823073e72","claim":"Michael Friedman was appointed as Chief Executive Officer at AnTix Holdings, Inc..","evidence_excerpt":"and Michael Friedman, the Company’s President and CFO, was appointed as CEO of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1331612/000147793224002284/0001477932-24-002284-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c2597770e2","claim":"Merle Griff was terminated as Chief Executive Officer at AnTix Holdings, Inc..","evidence_excerpt":"On April 18, 2024, Innovative MedTech, Inc. (the “Company”) terminated Merle Griff, PhD., as the Company’s CEO","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1331612/000147793224002284/0001477932-24-002284-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}